Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India
· Delayed Price · Currency is INR 1,320.90
+30.30 (2.35%)
Jun 6, 2025, 3:29 PM IST
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,048 employees as of March 31, 2024. The number of employees increased by 1,185 or 4.58% compared to the previous year.
Employees
27,048
Change (1Y)
1,185
Growth (1Y)
4.58%
Revenue / Employee
12.04M INR
Profits / Employee
2.09M INR
Market Cap
1,100.26B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Apollo Hospitals Enterprise | 83,147 |
| Mankind Pharma | 19,540 |
| Zydus Lifesciences | 26,921 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
Dr. Reddy's Laboratories News
- 1 day ago - Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug - Benzinga
- 1 day ago - Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug - Benzinga
- 1 day ago - Alvotech and Dr. Reddy's Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) - Business Wire
- 1 day ago - Nifty 50 top gainers today, June 5: Eternal, Trent, Dr. Reddy’s, Power Grid, ICICI Bank and more - Business Upturn
- 1 day ago - Alvotech and Dr. Reddy’s partner to co-develop biosimilar candidate for Keytruda (pembrolizumab) - Seeking Alpha
- 1 day ago - Dr. Reddy’s shares surge 4% after company partners with Alvotech to develop and commercialize Biosimilar to Keytruda - Business Upturn
- 1 day ago - Dr. Reddy’s and Alvotech partner to develop and commercialize Biosimilar to Keytruda - Business Upturn
- 18 days ago - Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus - Business Upturn